Current and historical daily PE Ratio for Philip Morris International Inc (
) from 2014 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Philip Morris International stock (XTER:4I1) PE ratio as of Jun 20 2024 is 19.77.
More Details
Philip Morris International Inc (XTER:4I1) PE Ratio (TTM) Chart
Philip Morris International Inc (XTER:4I1) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1259
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Philip Morris International PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-21 | 20.3 | 2024-04-17 | 17.8 |
2024-06-19 | 19.9 | 2024-04-16 | 17.8 |
2024-06-18 | 20.0 | 2024-04-15 | 17.7 |
2024-06-17 | 20.0 | 2024-04-12 | 17.6 |
2024-06-14 | 20.2 | 2024-04-11 | 17.6 |
2024-06-13 | 20.1 | 2024-04-10 | 17.5 |
2024-06-12 | 20.1 | 2024-04-09 | 17.7 |
2024-06-11 | 20.4 | 2024-04-08 | 17.5 |
2024-06-10 | 20.3 | 2024-04-05 | 17.5 |
2024-06-07 | 20.4 | 2024-04-04 | 17.7 |
2024-06-06 | 20.3 | 2024-04-03 | 17.8 |
2024-06-05 | 20.1 | 2024-04-02 | 18.0 |
2024-06-04 | 20.1 | 2024-03-28 | 18.0 |
2024-06-03 | 19.8 | 2024-03-27 | 18.1 |
2024-05-31 | 19.6 | 2024-03-26 | 18.0 |
2024-05-30 | 19.4 | 2024-03-25 | 18.1 |
2024-05-29 | 19.4 | 2024-03-22 | 18.5 |
2024-05-28 | 19.4 | 2024-03-21 | 18.3 |
2024-05-27 | 19.7 | 2024-03-20 | 18.4 |
2024-05-24 | 19.4 | 2024-03-19 | 18.9 |
2024-05-23 | 19.5 | 2024-03-18 | 18.8 |
2024-05-22 | 19.7 | 2024-03-15 | 18.5 |
2024-05-21 | 19.5 | 2024-03-14 | 18.5 |
2024-05-20 | 19.5 | 2024-03-13 | 18.8 |
2024-05-17 | 19.5 | 2024-03-12 | 18.5 |
2024-05-16 | 19.6 | 2024-03-11 | 18.4 |
2024-05-15 | 19.5 | 2024-03-08 | 18.2 |
2024-05-14 | 19.4 | 2024-03-07 | 18.0 |
2024-05-13 | 19.5 | 2024-03-06 | 18.0 |
2024-05-10 | 19.5 | 2024-03-05 | 17.8 |
2024-05-09 | 19.3 | 2024-03-04 | 17.8 |
2024-05-08 | 19.2 | 2024-03-01 | 17.7 |
2024-05-07 | 19.1 | 2024-02-29 | 18.0 |
2024-05-06 | 19.0 | 2024-02-28 | 17.8 |
2024-05-03 | 19.1 | 2024-02-27 | 17.9 |
2024-05-02 | 19.2 | 2024-02-26 | 17.9 |
2024-04-30 | 18.7 | 2024-02-23 | 18.2 |
2024-04-29 | 18.8 | 2024-02-22 | 18.0 |
2024-04-26 | 18.9 | 2024-02-21 | 17.9 |
2024-04-25 | 19.5 | 2024-02-20 | 17.8 |
2024-04-24 | 19.3 | 2024-02-19 | 17.9 |
2024-04-23 | 19.0 | 2024-02-16 | 17.9 |
2024-04-22 | 18.6 | 2024-02-15 | 17.8 |
2024-04-19 | 18.3 | 2024-02-14 | 17.8 |
2024-04-18 | 18.0 | 2024-02-13 | 17.9 |
Philip Morris International Inc (XTER:4I1) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
![Philip Morris International Inc Philip Morris International Inc logo](https://static.gurufocus.com/logos/0C00000ZNN.png?14)
Philip Morris International Inc
NAICS : 312230
SIC : 2111
ISIN : US7181721090
Share Class Description:
XTER:4I1: Ordinary SharesCompare
Compare
Traded in other countries / regions
PM.USA0M8V.UK4I1.GermanyPM.MexicoPMI.SwitzerlandPHMO34.Brazil1PM.ItalyPMOR.Austria IPO Date
2014-06-26Description
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from cigarettes with the acquisition in 2022 of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches, primarily in the US and Scandinavia. It diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.